相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome
Zi-Jiang Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial
Jessica Lefebvre et al.
FERTILITY AND STERILITY (2015)
Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa
F. Olivennes et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2015)
Freeze-all policy: is it time for that?
Matheus Roque
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2015)
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection
Joan-Carles Arce et al.
FERTILITY AND STERILITY (2014)
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice
Antonio La Marca et al.
HUMAN REPRODUCTION UPDATE (2014)
Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification
Parvin Tajik et al.
CLINICAL CANCER RESEARCH (2013)
Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis
Simone L. Broer et al.
FERTILITY AND STERILITY (2013)
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach
Simone L. Broer et al.
HUMAN REPRODUCTION UPDATE (2013)
Can anti-Mullerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?
R. Fleming et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2013)
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count
Antonio La Marca et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles
A. La Marca et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)
The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial
Theodora C. van Tilborg et al.
BMC WOMENS HEALTH (2012)
Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model
Lobke M. Moolenaar et al.
FERTILITY AND STERILITY (2011)
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles
Sesh Kamal Sunkara et al.
HUMAN REPRODUCTION (2011)
Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF
A. P. Yates et al.
HUMAN REPRODUCTION (2011)
Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis
M. D. Sterrenburg et al.
HUMAN REPRODUCTION UPDATE (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients
Ernesto Bosch et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study
F. Olivennes et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2011)
Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation
Luciano G. Nardo et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2011)
A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count
K. Jayaprakasan et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2010)
What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?
Murat Berkkanoglu et al.
FERTILITY AND STERILITY (2010)
Preventing ovarian hyperstimulation syndrome: guidance for the clinician
Peter Humaidan et al.
FERTILITY AND STERILITY (2010)
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
A. La Marca et al.
HUMAN REPRODUCTION UPDATE (2010)
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count
Simtone L. Broer et al.
FERTILITY AND STERILITY (2009)
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Scott M. Nelson et al.
HUMAN REPRODUCTION (2009)
Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study
F. Olivennes et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve
Dharmawijaya N. Lekamge et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2008)
The ISMAAR proposal on terminology for ovarian stimulation for IVF
G. Nargund et al.
HUMAN REPRODUCTION (2007)
Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human
P. G. Groothuis et al.
HUMAN REPRODUCTION UPDATE (2007)
A systematic review of tests predicting ovarian reserve and IVF outcome
F. J. Broekmans et al.
HUMAN REPRODUCTION UPDATE (2006)
Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients
C. M. Howles et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial
ER Klinkert et al.
HUMAN REPRODUCTION (2005)
A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram
B Popovic-Todorovic et al.
HUMAN REPRODUCTION (2003)
A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment
PYK Yong et al.
FERTILITY AND STERILITY (2003)
A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment
B Popovic-Todorovic et al.
HUMAN REPRODUCTION (2003)
The variability of female reproductive ageing
ERT Velde et al.
HUMAN REPRODUCTION UPDATE (2002)
A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles
RF Harrison et al.
FERTILITY AND STERILITY (2001)
分享论文
